Rapport Therapeutics, Inc. Common Stock (RAPP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 484.69M | 498.56M | 520.66M | 270.24M | 290.97M | 309.8M | 325.94M | 340.67M | 198.73M | 150.87M |
| Cash & Short-Term Investments | 476.78M | 490.54M | 513.03M | 260.45M | 285.38M | 305.28M | 320.66M | 336.14M | 193.24M | 147.48M |
| Cash Only | 78.06M | 52.65M | 251.36M | 55.07M | 57.6M | 56.8M | 39.31M | 110.16M | 74.27M | 70.17M |
| Short-Term Investments | 398.73M | 437.89M | 261.67M | 205.38M | 227.78M | 248.47M | 281.35M | 225.97M | 118.98M | 77.31M |
| Accounts Receivable | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 0.26 | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.86M | 8.02M | 7.63M | 9.79M | 5.59M | 4.52M | 5.28M | 4.53M | 5.48M | 3.39M |
| Total Non-Current Assets | 12.9M | 13.87M | 14.66M | 15.25M | 11.09M | 5.13M | 5.21M | 5.43M | 7.56M | 4.55M |
| Property, Plant & Equipment | 11.85M | 12.88M | 13.6M | 14.22M | 10.87M | 4.97M | 5.02M | 5.24M | 5.49M | 4M |
| Fixed Asset Turnover | 1.62x | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.06M | 985K | 1.07M | 1.03M | 211K | 160K | 189K | 189K | 2.07M | 551K |
| Total Assets | 497.6M | 512.43M | 535.32M | 285.5M | 302.05M | 314.93M | 331.14M | 346.1M | 206.29M | 155.42M |
| Asset Turnover | 0.04x | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 64.74% | 62.71% | 61.66% | -17.51% | 46.42% | 102.63% | - | - | - | - |
| Total Current Liabilities | 17.9M | 19.05M | 14.32M | 11.88M | 9.38M | 8.77M | 7.1M | 8.1M | 9.88M | 8.8M |
| Accounts Payable | 6.56M | 4.19M | 3.23M | 3.18M | 2.14M | 1.95M | 1.32M | 1.88M | 1.45M | 2.5M |
| Days Payables Outstanding | 2.13K | 1.29K | - | - | - | 579.78 | 671.73 | 726.91 | 1.18K | 12.02K |
| Short-Term Debt | 2.62M | 2.75M | 2.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.72M | 12.1M | 8.6M | 3.14M | 2.1M | 3.71M | 3.23M | 1.71M | 1.04M | 2.41M |
| Current Ratio | 27.08x | 26.17x | 36.37x | 22.75x | 31.01x | 35.34x | 45.91x | 42.08x | 20.10x | 17.14x |
| Quick Ratio | 27.08x | 26.17x | 36.37x | 22.75x | 31.01x | 35.34x | 45.91x | 42.08x | 20.10x | 17.14x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 8.19M | 8.73M | 9.39M | 10.1M | 6.83M | 739K | 931K | 1.12M | 236.04M | 172.25M |
| Long-Term Debt | 8.19M | 8.73M | 9.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 10.1M | 6.83M | 739K | 931K | 1.12M | 1.3M | 1.48M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234.74M | 170.78M |
| Total Liabilities | 26.09M | 27.78M | 23.71M | 21.98M | 16.22M | 9.51M | 8.03M | 9.21M | 245.92M | 181.06M |
| Total Debt | 10.8M | 11.48M | 11.87M | 11.86M | 7.84M | 1.48M | 1.65M | 1.82M | 1.98M | 2.15M |
| Net Debt | -67.25M | -41.16M | -239.49M | -43.2M | -49.76M | -55.33M | -37.66M | -108.34M | -72.28M | -68.02M |
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.05x | 0.03x | 0.00x | 0.01x | 0.01x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 471.51M | 484.65M | 511.62M | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M | -39.63M | -25.63M |
| Equity Growth % | 64.96% | 58.68% | 58.34% | -21.78% | 821.21% | 1291.49% | - | - | - | - |
| Book Value per Share | 9.98 | 10.32 | 13.49 | 7.43 | 14.82 | 15.83 | 16.85 | 16.75 | -2.04 | -1.42 |
| Total Shareholders' Equity | 471.51M | 484.65M | 511.62M | 263.51M | 285.84M | 305.43M | 323.11M | 336.89M | -39.63M | -25.63M |
| Common Stock | 48K | 48K | 48K | 37K | 37K | 37K | 36K | 36K | 4K | 4K |
| Retained Earnings | -255.09M | -235.23M | -201.47M | -174.54M | -147.81M | -123.75M | -103.77M | -86.23M | -68.11M | -45.44M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -505K | 546K | 145K | -76K | -95K | -522K | 400K | -183K | -160K | 4K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |